Correlation Between Nykode Therapeutics and Vicore Pharma

Can any of the company-specific risk be diversified away by investing in both Nykode Therapeutics and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nykode Therapeutics and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nykode Therapeutics ASA and Vicore Pharma Holding, you can compare the effects of market volatilities on Nykode Therapeutics and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nykode Therapeutics with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nykode Therapeutics and Vicore Pharma.

Diversification Opportunities for Nykode Therapeutics and Vicore Pharma

0.41

Correlation Coefficient

Nykode Therapeutics  Vicore Pharma

Very weak diversification

The 3 months correlation between Nykode and Vicore is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Nykode Therapeutics ASA and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and Nykode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nykode Therapeutics ASA are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of Nykode Therapeutics i.e., Nykode Therapeutics and Vicore Pharma go up and down completely randomly.

Pair Corralation between Nykode Therapeutics and Vicore Pharma

Assuming the 90 days trading horizon Nykode Therapeutics ASA is expected to generate 0.98 times more return on investment than Vicore Pharma. However, Nykode Therapeutics ASA is 1.02 times less risky than Vicore Pharma. It trades about 0.09 of its potential returns per unit of risk. Vicore Pharma Holding is currently generating about 0.06 per unit of risk. If you would invest  161.00  in Nykode Therapeutics ASA on April 23, 2025 and sell it today you would earn a total of  26.00  from holding Nykode Therapeutics ASA or generate 16.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Nykode Therapeutics ASA  vs.  Vicore Pharma Holding

Nykode Therapeutics ASA

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nykode Therapeutics ASA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating essential indicators, Nykode Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Vicore Pharma Holding

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Vicore Pharma Holding are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Vicore Pharma may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Nykode Therapeutics and Vicore Pharma

The main advantage of trading using opposite Nykode Therapeutics and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nykode Therapeutics position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.

The idea behind Nykode Therapeutics ASA and Vicore Pharma Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .